The Neuroprotection Market is experiencing robust expansion as global healthcare systems intensify efforts to combat rising neurological disorders, including Alzheimer’s disease, Parkinson’s disease, stroke, multiple sclerosis, and traumatic brain injuries. With a market valuation of USD 34,092.43 million in 2024 and a projected CAGR of 7.42% from 2025 to 2032, the industry is...